期刊文献+

肺康复治疗方案对急性期中重度COPD患者BODE指数的影响 被引量:9

Exploration of the pulmonary rehabilitation therapy on the BODE index of acute moderate and severe COPD patients
原文传递
导出
摘要 目的评估肺康复治疗方案对急性期中重度COPD患者BODE指数的影响。方法将在我院接受治疗的102例急性期中重度COPD患者,随机分为对照组和观察1组、观察2组,对照组接受常规治疗,观察1组在常规治疗的基础上给予患者有氧呼吸的训练,1次/d,20min/次;观察2组在观察1组治疗的基础上进行上下肢训练,1次/d,20min/次。5个疗程治疗结束后,测定3组患者在治疗后6分钟步行距离(6MWD)、FEVl%pred、体质量指数(BMI)、呼吸困难指数(MMRC),计算BODE指数。结果3组中度患者中观察1组、观察2组的6MWD差值分别为(30.1±5.0)m、(63.9±11.1)m,与对照组(10.1±1.1)m比较差异有统计学意义(P〈O.05);观察1组、观察2组的FEVl%pred差值分别为7.9±3.0,11.6±1.5,与对照组2.4±0.5比较差异均有统计学意义(P〈0.05);观察2组BMI差值为4.3±0.5,与对照组0.6±1.6比较差异有统计学意义(P〈O.05);观察1组和观察2组BODE指数差值依次为0.8±0.2,1.2±0.4,与对照组0.3±0.1比较差异有统计学意义(P〈O.05);3组重度患者中观察1组、观察2组的6MWD差值分别为(55.1±30.1)m,(87.0±22.6)m,与对照组(8.6±3.6)m比较差异有统计学意义(P〈O.05);观察1组、观察2组的FEV,%pred差值分别为7.6±1.2,10.9±1.0,与对照组1.9±1.1比较差异有统计学意义(P〈O.05);观察1组、观察2组BMI差值为2.9±1.2,5.3±1.4,与对照组1.0±0.6比较差异有统计学意义(P〈0.05);观察2组MMRC差值为1.5±0.3,与对照组0.3±0.1比较差异有统计学意义(P〈0.05);观察1组和观察2组BODE指数差值依次为0.9±0.1,1.4±0.6,与对照组0.4±0.1比较差异有统计学意义(P〈0.05);3组极重度患者中观察1组6MWD差值为(42.2±4.4)m,与对照组(3.0±1.6)m比较差异有统计学意义(P〈O.05);观察1组BMI差值为2.6±2.1,与对照组0.7±0.8比较差异有统计学意义(P〈O.05);观察1组MMRC差值为1.1±0.2,与对照组0.3±0.1比较差异有统计学意义(P〈0.05);观察1组BODE指数差值为1.3±1.0,与对照组0.3±0.5比较差异有统计学意义(P〈O.05)。结论对不同病变程度的COPD患者采用合理的最佳治疗方案,能有效改善患者的生活质量,对患者的积极康复有重要意义。 Objective To evaluate the effects of pulmonary rehabilitation therapy on the BODE index of patients with acute moderate and severe COPD. Methods One hundred and two acute moderate and severe COPD patients accepted treatment in our hospital were divided randomly into control group, observing group 1 and observing group 2. The control group was treated with conventional therapy, the observing group 1 was treated with aerobic respiration training (1 time per day, 20 minutes per time) combined with conventional therapy, and the observing group 2 was treated by upper and lower limb training (1 time per day,20 minutes per time) based on the the treatment method of the observing group 1. Data was collected among three groups after 5 courses of the treatment,including 6MWD, FEV1% pred, BMI,MMRC. Results Among moderate COPD patients in three groups, the difference value of the 6MWD between observing group 1 and observing group 2 was (30.1 ± 5.0) m, (63.9 ± 11.1) m respectively, which was statistical compared that in the control group ( P 〈0.05). The difference value of the FEV1% pred between observing group 1 and observing group 2 was 7.9±3.0, 11.6 ±1.5 respectively,which was statistical to compare that in the control group ( P 〈0.05). There was statistical meaning comparing the difference value of the BMI between observing group 2 (4.3± 0.5) and control group(0.6±1.6) ( P 〈0.05). The difference value of the BODE index between observing group 1 and observing group 2 was 0.8±0.2,1.2±0.4 respectively, and the difference value in the control group is 0.3± 0.1, both of the difference between observing group 1 and control group as well as between tobserving group 2 and control group was statistical ( P 〈0.05). Among severe COPD patients in three groups,the difference value of the 6MWD between observing group 1 and observing group 2 was (55.1±30.1) m,(87.0±22.6) m respectively,which was statistical to compare that in the control group ( P 〈0.05). The difference value of the FEV1% pred between observing group 1 and observing group 2 was 7.6±1.2,10.9±1.0 respectively,which was statistical to compare that in the control group ( P 〈0.05). There was statistical meaning comparing the difference value of the BMI between observing group 2 (5.3±1.4) and control group (1. 0±0.6) ( P d0.05). Which applied to the observing group 1 (2.9± 1.2) and control group ( P 〈0.05). The difference value of the MMRC between observing group 2 and control group was 1.5±0.3,0.3±0.1 respectively,the difference is obvious ( P d0.05). The difference value of the BODE index between observing group 1 and observing group 2 was 0.9 ± 0.1,1.4 ± 0.6 respectively,which was statistical to compare that in the control group ( P 〈0.05). Among extremely severe COPD patients in three groups,the difference value of the 6MWD between observing group 1 and control group was (42.2± 4.4) m, (3.0 ±1.6) m respectively, the difference between two groups is obvious (P 〈0.05). The difference value of the BMI in observing group 1 was 2.6 ± 2.1, which was statistical to compare that in the control group ( P 〈0.05). There was statistical meaning comparing the difference value of the MMRC between observing group 1 (5.3 ±1.4) and control group ( 1.0 ± 0.6) ( P〈 0.05). Which applied to the observing group 1 (1.1±0.2) and control group (0.3±0.1) ( P 〈0.05). The difference value of the MMRC between observing group 2 and control group was 1.5 ±0.3,0.3 ± 0.1 respectively,the difference is obvious (P 〈 0.05). The difference value of the BODE index between observing group 1 and control group was 1.3 ± 1.0,0.3 ± 0.5 respectively, which was statistical ( P 〈0.05). Conclusions Adopting reasonable optimal treatment program for different degrees of COPD patients can improve the patients life quality,which is of great significance to rehabilitation.
出处 《国际呼吸杂志》 2015年第3期183-187,共5页 International Journal of Respiration
关键词 肺康复 慢性阻塞性肺疾病 BODE指数 Pulmonary rehabilitation Chronic obstructive pulmonary disease BODE index
  • 相关文献

参考文献10

二级参考文献29

  • 1任蕾,李庆云,杜井波,周均铭,翁秋霖,陈小虎.不同严重度慢性阻塞性肺疾病患者肺康复策略比较[J].上海交通大学学报(医学版),2011,31(5):620-624. 被引量:24
  • 2有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 3陆再英,钟南山.内科学[M].北京:人民卫生出版社,2011:543-548.
  • 4Patil SP , Krishnan JA, Lechtzin N, et al. In hospital mortality fol- lowing acute exacerbations of COPD[ J]. Arch Intern Med, 2003, 163:1180 - 1186.
  • 5Groenewegen KH, Schols MW J , Wonters FM. Mortality and mor- tality-related factors after hospitalization for acute exacerbation of COPD[ J]. Chest, 2003,124:459 - 467.
  • 6GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989.
  • 7Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946.
  • 8Celli BR,Cote CG,Marin JM,ct al.The body mass index,airflow obstruction,dyspnea and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med,2004,350:1005-1012.
  • 9冉丕鑫 王辰 姚婉贞 等.我国部分地区慢性阻塞性肺疾病流行病学研究[J].中华结核和呼吸杂志,2007,.
  • 10张恒.早期肺康复对COPD患者治疗效果的影响[J].中外健康文摘,2012,9(10) :11 - 12.

共引文献8294

同被引文献86

引证文献9

二级引证文献221

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部